Contrasting In Vivo Effects of Two Peptide-Based Amyloid-β Protein Aggregation Inhibitors in a Transgenic Mouse Model of Amyloid Deposition
Previous studies have shown that 17,19,21-tri-N-methyl-Aβ16-22 peptide (Aβ16-22m), and a peptide analogue containing α,α-disubsituted amino acids (ααAA) in the hydrophobic core domain of Aβ, termed AMY-1, effectively inhibited full-length Aβ aggregation in vitro. To investigate the amyloid-modifying...
Main Authors: | Qingyou Li, Marcia Gordon, Marcus A. Etienne, Robert P. Hammer, Dave Morgan Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-04-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368908784423247 |
Similar Items
-
Folding and aggregation of amyloid peptides
by: Kittner, Madeleine
Published: (2011) -
Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage
by: Gordon Marcia N, et al.
Published: (2004-12-01) -
Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide.
by: Nasrollah Rezaei-Ghaleh, et al.
Published: (2011-01-01) -
Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-β peptide levels in vivo
by: Veronica Hirsch-Reinshagen, et al.
Published: (2007-04-01) -
Hydrodynamic effect on β-amyloid peptide aggregation
by: Chiricotto, Mara
Published: (2016)